Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 50, 2020 - Issue 9
412
Views
20
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Identification of rhythmic human CYPs and their circadian regulators using synchronized hepatoma cells

, , &
Pages 1052-1063 | Received 18 Feb 2020, Accepted 29 Feb 2020, Published online: 09 Mar 2020

References

  • Achour B, Barber J, Rostami-Hodjegan A. (2014). Expression of hepatic drug-metabolizing cytochrome p450 enzymes and their intercorrelations: a meta-analysis. Drug Metab Dispos 42:1349–56.
  • Akashi M, Nishida E. (2000). Involvement of the MAP kinase cascade in resetting of the mammalian circadian clock. Genes Dev 14:645–9.
  • Balsalobre A. (2002). Clock genes in mammalian peripheral tissues. Cell Tissue Res 309:193–9.
  • Balsalobre A, Damiola F, Schibler U. (1998). A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 93:929–37.
  • Chen M, Guan B, Xu H, et al. (2019a). The molecular mechanism regulating diurnal rhythm of flavin-containing monooxygenase 5 in mouse liver. Drug Metab Dispos 47:1333–42.
  • Chen M, Guo L, Dong D, et al. (2019b). The nuclear receptor Shp regulates morphine withdrawal syndrome via modulation of Ugt2b expression in mice. Biochem Pharmacol 161:163–72.
  • Gachon F, Firsov D. (2011). The role of circadian timing system on drug metabolism and detoxification. Expert Opin Drug Metab Toxicol 7:147–58.
  • Gauger MA, Sancar A. (2005). Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. Cancer Res 65:6828–34.
  • Gerets HH, Tilmant K, Gerin B, et al. (2012). Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol 28:69–87.
  • Gerber A, Esnault C, Aubert G, et al. (2013). Blood-borne circadian signal stimulates daily oscillations in actin dynamics and SRF activity. Cell 152:492–503.
  • Guengerich FP. (1992). Characterization of human cytochrome P450 Enzymes. Faseb J 6:745–8.
  • Guo L, Yu F, Zhang T, Wu B. (2018). The clock protein bmal1 regulates circadian expression and activity of sulfotransferase 1a1 in Mice. Drug Metab. Dispos 46:1403–10.
  • Hogenesch JB. (2006). Feedback repression is required for mammalian circadian clock function. Nat. Genet 38:31–319.
  • Hrycay EG, Bandiera SM. (2009). Expression, function and regulation of mouse cytochrome P450 enzymes: comparison with human cytochrome P450 enzymes. Curr Drug Metab 10:1151–83.
  • Lin Y, Wang S, Zhou Z, et al. (2019). Bmal1 regulates circadian expression of cytochrome P450 3a11 and drug metabolism in mice. Commun Biol 2:378.
  • Matsunaga N, Ikeda M, Takiguchi T, et al. (2008). The molecular mechanism regulating 24-hour rhythm of CYP2E1 expression in the mouse liver. Hepatology 48:240–51.
  • Matsunaga N, Inoue M, Kusunose N, et al. (2012). Time-dependent interaction between differentiated embryo chondrocyte-2 and CCAAT/enhancer-binding protein α underlies the circadian expression of CYP2D6 in serum-shocked HepG2 cells. Mol Pharmacol 81:739–47.
  • Mcnamara P, Seo SP, Rudic RD, et al. (2001). Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock. Cell 105:877–89.
  • Min DI, Chen HY, Lee MK, et al. (1997). Time-dependent disposition of tacrolimus and its effect on endothelin-1 in liver allograft recipients. Pharmacotherapy 17:457–63.
  • Minami Y, Ode KL, Ueda HR. (2013). Mammalian circadian clock: the roles of transcriptional repression and delay. Handb Exp Pharmacol 217:359–77.
  • Mitsui S, Yamaguchi S, Matsuo T, et al. (2001). Antagonistic role of E4BP4 and PAR proteins in the circadian oscillatory mechanism. Genes Dev 15:995–1006.
  • Nagoshi E, Brown SA, Dibner C, et al. (2005). Circadian gene expression in cultured cells. Meth. Enzymol 393:543–57.
  • Nebert DW, Russell DW. (2002). Clinical importance of the cytochromes P450. Lancet 360:1155–62.
  • Ohno M, Yamaguchi I, Ito T, et al. (2000). Circadian variation of the urinary 6beta-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity. Eur J Clin Pharmacol 55:861–5.
  • Parkinson A, Ogilvie BW. (2008). Biotransformation of xenobiotics. In: Klaassen CD, ed Casarett and Doull’s toxicology. New York: McGraw-Hill, 161–304.
  • Paschos GK, Baggs JE, Hogenesch JB, FitzGerald GA. (2010). The role of clock genes in pharmacology. Annu Rev Pharmacol Toxicol 50:187–214.
  • Ralph MR, Foster RG, Davis FC, Menaker M. (1990). Transplanted suprachiasmatic nucleus determines circadian period. Science 247:975–8.
  • Rendic S. (2002). Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev 34:83–448.
  • Robertson LM, Takahashi JS. (1988). Circadian clock in cell culture: II. In vitro photic entrainment of melatonin oscillation from dissociated chick pineal cells. J. Neurosci 8:22–30.
  • Sato TK, Yamada RG, Ukai H, et al. (2006). Feedback repression is required for mammalian circadian clock function. Nat. Genet 38:312–9.
  • Smith RB, Kroboth PD, Phillips JP. (1986). Temporal variation in triazolam pharmacokinetics and pharmacodynamics after oral administration. J Clin Pharmacol 26:120–4.
  • Takiguchi T, Tomita M, Matsunaga N, et al. (2007). Molecular basis for rhythmic expression of CYP3A4 in serum-shocked HepG2 cells. Pharmacogenet Genom 17:1047–56.
  • Torimoto N, Ishii I, Hata M, et al. (2003). Direct interaction between substrates and endogenous steroids in the active site may change the activity of cytochrome P450 3A4. Biochemistry 42:15068–77.
  • Yagita K, Okamura H. (2000). Forskolin induces circadian gene expression of rPer1, rPer2 and dbp in mammalian rat-1 fibroblasts. FEBS Lett 465:79–82.
  • Yagita K, Tamanini F, van Der Horst GT, Okamura H. (2001). Molecular mechanisms of the biological clock in cultured fibroblasts. Science 292:278–81.
  • Yu F, Zhang T, Zhou C, et al. (2019). The Circadian Clock Gene Bmal1 Controls Intestinal Exporter MRP2 and Drug Disposition. Theranostics 9:2754–67.
  • Zanger UM, Schwab M. (2013). Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138:103–41.
  • Zhang T, Guo L, Yu F, et al. (2019). The nuclear receptor Rev-erbα participates in circadian regulation of Ugt2b enzymes in mice. Pharmacology 161:89–97.
  • Zhang T, Yu F, Guo L, et al. (2018). Small heterodimer partner regulates circadian cytochromes p450 and drug-induced hepatotoxicity. Theranostics 8:5246–58.
  • Zhang YJ, Yeager RL, Klaassen CD. (2009). Circadian expression profiles of drug-processing genes and transcription factors in mouse liver. Drug Metab Dispos 37:106–15.
  • Zhao M, Xing H, Chen M, et al. (2019a). Circadian clock-controlled drug metabolism and transport. Xenobiotica 1:1–11.
  • Zhao M, Zhao H, Deng J, et al. (2019b). Role of the Clock protein in liver detoxification. Br J Pharmacol 176:4639–52.
  • Zuber R, Anzenbacherová E, Anzenbacher P. (2002). Cytochromes P450 and experimental models of drug metabolism. J Cell Mol Med 6:189–98.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.